Quantcast

Latest Immunosuppressive drug Stories

2014-05-28 12:42:51

University of Gothenburg A newly discovered tick-borne bacterium known as “Candidatus Neoehrlichia mikurensis” has been implicated in six cases of disease in Sweden. A new international study led by the Sahlgrenska Academy has shown that this bacterium is primarily a risk for people who are already sick and who are receiving immunosuppressive drugs. The Candidatus Neoehrlichia mikurensis bacterium, known in the medical world by its short name Neoehrlichia, was discovered and...

2014-05-01 12:32:14

WASHINGTON, May 1, 2014 /PRNewswire-USNewswire/ -- Today RPA joins 14 other kidney organizations to promote changes in kidney care on Capitol Hill. Participants in Kidney Community Advocacy Day represent health professionals and kidney patients and will meet with elected officials and their staff to discuss issues that will improve the treatment and quality of life for millions of Americans: increasing federal investment in kidney research, and extending lifetime immunosuppressive drug...

2014-04-03 12:58:10

New research suggests that drugs commonly used to prevent organ rejection after transplantation may also be helpful for combating HIV. The findings, which are published in the American Journal of Transplantation, suggest a new strategy in the fight against HIV and AIDS. Despite the effectiveness of antiviral therapies at suppressing HIV, the virus still persists indefinitely at low levels in infected patients who are diligent about taking their medications. "Current therapies fail to cure...

2014-03-28 12:21:53

DUBLIN, Mar. 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/lwpmln/investigation ) has announced the addition of the "Investigation Report on China Tacrolimus Market, 2009-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Tacrolimus, also named as ""FK506"" and ""FR-900506"", was developed by Fujisawa Pharmaceutical Co., Ltd. (later became Astellas Pharma by merging with Yamanouchi Pharmaceutical Co.,...

2014-03-13 16:27:23

Decision Alleviates Concerns Over Potential for Organ Rejections, Preserves Physician Discretion Over Patient Care WASHINGTON, March 13, 2014 /PRNewswire-USNewswire/ -- Kidney Care Partners (KCP) voiced strong support for Centers for Medicare & Medicaid Services (CMS) Administrator Marilyn Tavenner's announcement that CMS would not finalize proposals to lift the protected class definition on three drug classes, including life-sustaining immunosuppressive drugs, that transplant...

2014-01-16 16:24:09

AUSTIN, Texas, Jan. 16, 2014 /PRNewswire/ -- XBiotech announced today that it has launched a Phase II study to treat a rare but debilitating disorder, Pyoderma Gangrenosum (PG). This study is based on efficacy seen with anti-IL-1 therapeutic antibody in previous dermatological clinical studies such as psoriasis and acne. PG is expected to be considered an "orphan indication" by the FDA, facilitating expedited clinical development to market. Dr. Armand Cognetta, lead clinical...

2013-11-21 13:04:03

Genomic analysis of transplant patients finds an opportunistic microorganism whose elevated presence could be used an indicator in treatment More than 260,000 Americans are alive today thanks to transplant operations that have replaced their failing kidneys, hearts, lungs or livers with healthy organs donated by volunteers or accident victims. But treatment doesn't end with surgery. Transplant recipients follow strict drug regimens designed to suppress their immune systems just enough...

2013-10-24 12:06:43

Discontinuing mycophenolate acid products does not seem to pose risks of transplant rejection Research suggests that fetal exposure to mycophenolic acid products (MPA)—which are drugs taken by transplant recipients to prevent rejection—may increase the risk of birth defects and spontaneous abortions. Results of this study will be presented at ASN Kidney Week 2013 November 5-10 at the Georgia World Congress Center in Atlanta, GA. To investigate these potential links, Serban...

2013-08-23 10:38:07

NIH-funded study provides more evidence supporting development of noninvasive tests Levels of a protein in the urine of kidney transplant recipients can distinguish those at low risk of developing kidney injury from those at high risk, a study suggests. The results also suggest that low levels of this protein, called CXCL9, can rule out rejection as a cause of kidney injury. The study appears online Aug. 22 in the American Journal of Transplantation. The work was funded by the National...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related